recall
saveSOMERSET THERAPEUTICS LLC recall (Cls II)
March 25, 2026updated 5mo ago
community read0 votes
Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 70069-025-01 — Reason: Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate. — Status: Ongoing
view source ↗Data sources
last refreshed 14m ago
Found something off?
same company · ±60 days · 2
🐶 often sniffed alongside
top 8- tagRecall23 co-mentions · 13 sources
- drugHALOPERIDOL11 co-mentions · 7 sources
- drugHALOPERIDOL DECANOATE11 co-mentions · 7 sources
- drugdexamethasone SR6 co-mentions · 1 sources
- drugCISATRACURIUM BESYLATE6 co-mentions · 3 sources
- drugdexamethasone sodium phosphate SR4 co-mentions · 1 sources
- drugdexamethasone sodium phosphate4 co-mentions · 1 sources
- drugatropine2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that